cdfx is at the forefront of developing advanced precision neuroscience tools for diagnostic purposes and therapeutic exploration. By harnessing the progress made in genomic disease signatures, and leveraging state-of-the-art AI models, they are constructing highly detailed disease maps specific to dementia. These maps serve as a foundation for identifying new targets for drug development and creating accurate diagnostic tools that greatly enhance early detection and intervention capabilities.